These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3447704)

  • 1. [Clinical use of slow-release isosorbide-5-mononitrate in cardiac insufficiency].
    Caponnetto S; Canale C; Terrachini V; Masperone MA
    Cardiologia; 1987 Nov; 32(11):1303-9. PubMed ID: 3447704
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ergometric evaluation of slow-release isosorbide-5-mononitrate in exertional angina with stable threshold].
    Fazzini PF; Pucci P
    Cardiologia; 1987 Nov; 32(11):1297-302. PubMed ID: 3447703
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term tolerance and effect of isosorbide-5-mononitrate in comparison to isosorbide dinitrate (ISDN retard) in patients with coronary disease].
    Smolarz A; Seeliger S; Glocke M
    Med Welt; 1981 Apr; 32(14A):548-53. PubMed ID: 6787385
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative invasive examination of the effect of isosorbide-5-mononitrate and isosorbide dinitrate in chronic coronary insufficiency].
    Bödigheimer K; Nowak FG; Delius W
    Med Welt; 1981 Apr; 32(14A):543-7. PubMed ID: 7242318
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
    Schiavoni G; Bosimini E; Amico C
    Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative clinical trial of isosorbide 5-mononitrate and sustained-release isosorbide dinitrate in ischaemic heart disease.
    Neuhaus R; Johnen R; Vydra L; Solbach C
    Pharmatherapeutica; 1986; 4(8):486-95. PubMed ID: 3086899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the anti-angina effect and effect duration of isosorbide dinitrate, isosorbide-2-mononitrate (IS-2-MN) and isosorbide-5-mononitrate (IS-5-MN)].
    Reifart N; Reifart F; Kaltenbach M; Bussmann WD
    Med Welt; 1981 Apr; 32(14A):524-6. PubMed ID: 7242313
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized crossover trial of isosorbide mononitrate (Elantan 20) and slow-release glyceryl trinitrate in the treatment of angina pectoris.
    Brodie NH; O'Hara H; O'Hara J; Valle-Jones JC
    Pharmatherapeutica; 1985; 4(6):367-75. PubMed ID: 3936056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic use of isosorbide 5-mononitrate in patients with heart failure.
    Stephens JD; Marks C; Woodings D; Vandenburg MJ
    Cardiology; 1987; 74 Suppl 1():69-71. PubMed ID: 3607807
    [No Abstract]   [Full Text] [Related]  

  • 10. [Delayed-action isosorbide-5-mononitrate preparations--are there differences in the acute effect?].
    Jansen W; Geppert R; Weidmann B; Tauchert M
    Med Klin (Munich); 1987 Nov; 82(24):854-9. PubMed ID: 3431518
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effectiveness of the delayed-action form of isosorbide 5-mononitrate in ischemic heart disease].
    Hůla J; Trhlíková M
    Vnitr Lek; 1991 Mar; 37(3):248-54. PubMed ID: 2031313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release isosorbide-5-mononitrate in angina pectoris: a comparison with standard formulation isosorbide dinitrate.
    Parker JO
    Can J Cardiol; 1991 Apr; 7(3):125-30. PubMed ID: 2044014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemodynamic effects of isosorbide dinitrate (Isomack Retard capsules) in chronic heart failure].
    Stejfa M; Vítovec J; Blaha M; Roubalík P
    Vnitr Lek; 1988 Aug; 34(8):772-6. PubMed ID: 3176367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Functional activity of platelet guanylate cyclase and cardiac hemodynamics in patients with chronic heart failure and relevant changes after treatment with isosorbide-5-mononitrate].
    Ol'binskaia LI; Ushakova AV; Sizova ZhM
    Ter Arkh; 1999; 71(9):77-9. PubMed ID: 10553632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and hemodynamic evaluation of isosorbide dinitrate therapy in heart failure (author's transl)].
    Miranda V; Saavedra J; Opazo JA; Stockins B; Contreras M; Lanas F
    Rev Med Chil; 1979 Aug; 107(8):721-3. PubMed ID: 545565
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hemodynamic and isotope study of the effects of sublingual and oral administration of isosorbide dinitrate in cardiac insufficiency].
    Chiche P; Baligadoo S
    Coeur Med Interne; 1976; 15(3):361-77. PubMed ID: 791567
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-anginal and anti-ischemic efficacy of conventional and slow release formulations of isosorbide-5-mononitrate in angina pectoris.
    Thadani U
    Z Kardiol; 1985; 74 Suppl 4():21-4. PubMed ID: 4096067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of a new slow-release isosorbide dinitrate preparation in myocardial infarction (author's transl)].
    Stein G; Glocke M; Teufel W
    Med Klin; 1975 Jul; 70(27):1179-84. PubMed ID: 1177789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of the changes produced by nitrates in patients with chronic heart insufficiency].
    Almenar L; Gimeno JV; Sotillo J; Moreno MT; Salvador A; Miró V; Mora V; Martínez Dolz L; Algarra F
    Rev Esp Cardiol; 1993 May; 46(5):298-303. PubMed ID: 8516538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
    Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
    Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.